A naukri.com initiative
Bioengineer
1w
21
Image Credit: Bioengineer
Promising New Therapy Emerges for Genetic Eye Disorder Retinitis Pigmentosa
- Researchers have discovered two new non-retinoid compounds for the treatment of retinitis pigmentosa which leads to blindness in individuals with genetic mutations. The compounds promote the correct folding of rhodopsin and facilitate its movement through cells, improving its functional expression at the surface of retinal cells.
- The compounds demonstrated significant efficacy in both in-vitro and in-vivo applications. They increased the cell surface expression of rhodopsin across 36 different genetic subtypes of retinitis pigmentosa and crossed the blood-brain and blood-retina barriers.
- The compounds showed promise as safer alternative therapeutic options compared to existing treatments such as retinoid compounds, which are associated with light sensitivity and toxicity.
- The research highlights the need for extensive testing to ensure the compounds' long-term efficacy and safety before human trials can commence.
- The study used virtual screening methodologies to identify potential therapeutic candidates swiftly and emphasizes the importance of international collaborations in scientific research.
- The research instigates further exploration into the molecular biophysics of protein folding and its implications for ocular health and inspires optimism in the development of future therapeutic options.
- With over a century of research into various forms of blindness, such discoveries suggest a future where individuals with retinitis pigmentosa may no longer face irreversible vision loss.
- The rigorous dedication of scientists to unearth solutions for genetic disorders like retinitis pigmentosa is a reminder of the relentless spirit of inquiry woven into the fabric of scientific exploration.
- The study was conducted by Beata Jastrzebska and her team from Case Western Reserve University and published in the open-access journal PLOS Biology on January 14.
- The article's keywords include Retinitis Pigmentosa, Rhodopsin, Gene Therapy, Small-Molecule Pharmacochaperones, Vision Restoration, Protein Misfolding, Experimental Treatments, Ocular Health, and Drug Discovery.
Read Full Article
1 Like
For uninterrupted reading, download the app